{"id":1877,"date":"2023-05-26T15:22:30","date_gmt":"2023-05-26T13:22:30","guid":{"rendered":"https:\/\/solmed-clinic.com\/?post_type=ispitivanja&#038;p=1877"},"modified":"2024-04-09T21:57:21","modified_gmt":"2024-04-09T19:57:21","slug":"squamous-cell-carcinoma","status":"publish","type":"ispitivanja","link":"https:\/\/solmed-clinic.com\/en\/ispitivanja\/squamous-cell-carcinoma\/","title":{"rendered":"Squamous Cell Carcinoma of the Skin"},"content":{"rendered":"<h3>Location: Special Hospital Medico (Rijeka)<\/h3>\n<p><strong>Study Drug:<\/strong> Experimental immunotherapy targeting the PD-L1 pathway, enhancing lymphocytes&#8217; ability to destroy cancer cells more effectively.<\/p>\n<p><strong>Main Inclusion Criteria:<\/strong> Patients with locally advanced, inoperable, or metastatic squamous cell carcinoma of the skin who have not previously been treated with radiotherapy or systemic oncologic therapy. Patients who have undergone surgery in the past, and experienced a recurrence of the disease, may have received prior adjuvant treatment.<\/p>\n<h3>Status: <span style=\"color: #339966;\">Enrolling patients<\/span><\/h3>\n<p>Expected Start of Patient Enrollment: January 2024<\/p>\n<p>Planned completion of new patient enrollment: August 2024<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Study Drug: Experimental immunotherapy targeting the PD-L1 pathway, enhancing lymphocytes&#8217; ability to destroy cancer cells more effectively.<\/p>\n","protected":false},"featured_media":1853,"template":"","status_ispitivanja":[80],"podrucja":[127],"class_list":["post-1877","ispitivanja","type-ispitivanja","status-publish","has-post-thumbnail","hentry","status_ispitivanja-active-does-not-include-patients","podrucja-oncology"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.1.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Squamous Cell Carcinoma of the Skin - Solmed Clinic<\/title>\n<meta name=\"description\" content=\"Advanced squamous cell carcinoma (aSCC), inhibitor of programmed cell death ligand 1 (PD-L1), oral treatment, tablet\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/solmed-clinic.com\/en\/ispitivanja\/squamous-cell-carcinoma\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Squamous Cell Carcinoma of the Skin - Solmed Clinic\" \/>\n<meta property=\"og:description\" content=\"Advanced squamous cell carcinoma (aSCC), inhibitor of programmed cell death ligand 1 (PD-L1), oral treatment, tablet\" \/>\n<meta property=\"og:url\" content=\"https:\/\/solmed-clinic.com\/en\/ispitivanja\/squamous-cell-carcinoma\/\" \/>\n<meta property=\"og:site_name\" content=\"Solmed Clinic\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/solmedgrupa\" \/>\n<meta property=\"article:modified_time\" content=\"2024-04-09T19:57:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/solmed-clinic.com\/wp-content\/uploads\/2023\/05\/aSCC.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"787\" \/>\n\t<meta property=\"og:image:height\" content=\"446\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/solmed-clinic.com\/en\/ispitivanja\/squamous-cell-carcinoma\/\",\"url\":\"https:\/\/solmed-clinic.com\/en\/ispitivanja\/squamous-cell-carcinoma\/\",\"name\":\"Squamous Cell Carcinoma of the Skin - Solmed Clinic\",\"isPartOf\":{\"@id\":\"https:\/\/solmed-clinic.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/solmed-clinic.com\/en\/ispitivanja\/squamous-cell-carcinoma\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/solmed-clinic.com\/en\/ispitivanja\/squamous-cell-carcinoma\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/solmed-clinic.com\/wp-content\/uploads\/2023\/05\/aSCC.jpeg\",\"datePublished\":\"2023-05-26T13:22:30+00:00\",\"dateModified\":\"2024-04-09T19:57:21+00:00\",\"description\":\"Advanced squamous cell carcinoma (aSCC), inhibitor of programmed cell death ligand 1 (PD-L1), oral treatment, tablet\",\"breadcrumb\":{\"@id\":\"https:\/\/solmed-clinic.com\/en\/ispitivanja\/squamous-cell-carcinoma\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/solmed-clinic.com\/en\/ispitivanja\/squamous-cell-carcinoma\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/solmed-clinic.com\/en\/ispitivanja\/squamous-cell-carcinoma\/#primaryimage\",\"url\":\"https:\/\/solmed-clinic.com\/wp-content\/uploads\/2023\/05\/aSCC.jpeg\",\"contentUrl\":\"https:\/\/solmed-clinic.com\/wp-content\/uploads\/2023\/05\/aSCC.jpeg\",\"width\":787,\"height\":446},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/solmed-clinic.com\/en\/ispitivanja\/squamous-cell-carcinoma\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Po\u010detna stranica\",\"item\":\"https:\/\/solmed-clinic.com\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Squamous Cell Carcinoma of the Skin\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/solmed-clinic.com\/#website\",\"url\":\"https:\/\/solmed-clinic.com\/\",\"name\":\"Solmed Clinic\",\"description\":\"Solutions in medicine\",\"publisher\":{\"@id\":\"https:\/\/solmed-clinic.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/solmed-clinic.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/solmed-clinic.com\/#organization\",\"name\":\"Solmed Clinic\",\"url\":\"https:\/\/solmed-clinic.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/solmed-clinic.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/solmed-clinic.com\/wp-content\/uploads\/2020\/04\/solmed-small.svg\",\"contentUrl\":\"https:\/\/solmed-clinic.com\/wp-content\/uploads\/2020\/04\/solmed-small.svg\",\"width\":482,\"height\":77,\"caption\":\"Solmed Clinic\"},\"image\":{\"@id\":\"https:\/\/solmed-clinic.com\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/solmedgrupa\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Squamous Cell Carcinoma of the Skin - Solmed Clinic","description":"Advanced squamous cell carcinoma (aSCC), inhibitor of programmed cell death ligand 1 (PD-L1), oral treatment, tablet","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/solmed-clinic.com\/en\/ispitivanja\/squamous-cell-carcinoma\/","og_locale":"en_US","og_type":"article","og_title":"Squamous Cell Carcinoma of the Skin - Solmed Clinic","og_description":"Advanced squamous cell carcinoma (aSCC), inhibitor of programmed cell death ligand 1 (PD-L1), oral treatment, tablet","og_url":"https:\/\/solmed-clinic.com\/en\/ispitivanja\/squamous-cell-carcinoma\/","og_site_name":"Solmed Clinic","article_publisher":"https:\/\/www.facebook.com\/solmedgrupa","article_modified_time":"2024-04-09T19:57:21+00:00","og_image":[{"width":787,"height":446,"url":"https:\/\/solmed-clinic.com\/wp-content\/uploads\/2023\/05\/aSCC.jpeg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/solmed-clinic.com\/en\/ispitivanja\/squamous-cell-carcinoma\/","url":"https:\/\/solmed-clinic.com\/en\/ispitivanja\/squamous-cell-carcinoma\/","name":"Squamous Cell Carcinoma of the Skin - Solmed Clinic","isPartOf":{"@id":"https:\/\/solmed-clinic.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/solmed-clinic.com\/en\/ispitivanja\/squamous-cell-carcinoma\/#primaryimage"},"image":{"@id":"https:\/\/solmed-clinic.com\/en\/ispitivanja\/squamous-cell-carcinoma\/#primaryimage"},"thumbnailUrl":"https:\/\/solmed-clinic.com\/wp-content\/uploads\/2023\/05\/aSCC.jpeg","datePublished":"2023-05-26T13:22:30+00:00","dateModified":"2024-04-09T19:57:21+00:00","description":"Advanced squamous cell carcinoma (aSCC), inhibitor of programmed cell death ligand 1 (PD-L1), oral treatment, tablet","breadcrumb":{"@id":"https:\/\/solmed-clinic.com\/en\/ispitivanja\/squamous-cell-carcinoma\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/solmed-clinic.com\/en\/ispitivanja\/squamous-cell-carcinoma\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/solmed-clinic.com\/en\/ispitivanja\/squamous-cell-carcinoma\/#primaryimage","url":"https:\/\/solmed-clinic.com\/wp-content\/uploads\/2023\/05\/aSCC.jpeg","contentUrl":"https:\/\/solmed-clinic.com\/wp-content\/uploads\/2023\/05\/aSCC.jpeg","width":787,"height":446},{"@type":"BreadcrumbList","@id":"https:\/\/solmed-clinic.com\/en\/ispitivanja\/squamous-cell-carcinoma\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Po\u010detna stranica","item":"https:\/\/solmed-clinic.com\/en\/"},{"@type":"ListItem","position":2,"name":"Squamous Cell Carcinoma of the Skin"}]},{"@type":"WebSite","@id":"https:\/\/solmed-clinic.com\/#website","url":"https:\/\/solmed-clinic.com\/","name":"Solmed Clinic","description":"Solutions in medicine","publisher":{"@id":"https:\/\/solmed-clinic.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/solmed-clinic.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/solmed-clinic.com\/#organization","name":"Solmed Clinic","url":"https:\/\/solmed-clinic.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/solmed-clinic.com\/#\/schema\/logo\/image\/","url":"https:\/\/solmed-clinic.com\/wp-content\/uploads\/2020\/04\/solmed-small.svg","contentUrl":"https:\/\/solmed-clinic.com\/wp-content\/uploads\/2020\/04\/solmed-small.svg","width":482,"height":77,"caption":"Solmed Clinic"},"image":{"@id":"https:\/\/solmed-clinic.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/solmedgrupa"]}]}},"_links":{"self":[{"href":"https:\/\/solmed-clinic.com\/en\/wp-json\/wp\/v2\/ispitivanja\/1877","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/solmed-clinic.com\/en\/wp-json\/wp\/v2\/ispitivanja"}],"about":[{"href":"https:\/\/solmed-clinic.com\/en\/wp-json\/wp\/v2\/types\/ispitivanja"}],"version-history":[{"count":7,"href":"https:\/\/solmed-clinic.com\/en\/wp-json\/wp\/v2\/ispitivanja\/1877\/revisions"}],"predecessor-version":[{"id":3474,"href":"https:\/\/solmed-clinic.com\/en\/wp-json\/wp\/v2\/ispitivanja\/1877\/revisions\/3474"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/solmed-clinic.com\/en\/wp-json\/wp\/v2\/media\/1853"}],"wp:attachment":[{"href":"https:\/\/solmed-clinic.com\/en\/wp-json\/wp\/v2\/media?parent=1877"}],"wp:term":[{"taxonomy":"status_ispitivanja","embeddable":true,"href":"https:\/\/solmed-clinic.com\/en\/wp-json\/wp\/v2\/status_ispitivanja?post=1877"},{"taxonomy":"podrucja","embeddable":true,"href":"https:\/\/solmed-clinic.com\/en\/wp-json\/wp\/v2\/podrucja?post=1877"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}